4
Changes in Ownership
Adaptimmune Therapeutics PLC Filed Acc 0000947871-17-000255
Director bought 1,190,476 shares at $4.20 ($4,999,999)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC Director | 2017-03-27 | Purchase | +1,190,476 | $4.20 | $4,999,999 | 6,149,377 | I: show line 1 in the form |
| Open-market purchases · 1,190,476 sh · avg $4.20 · $4,999,999 | |||||||
Loading xslF345X03/ss36710_4.xml…